Gilman Hill Asset Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Gilman Hill Asset Management’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,605	Closed	-$479K	–	191
2015 Q2	$479K	Buy	11,605 +1,185	+11%	+$42.5K	0.23%	91
2015 Q1	$367K	Buy	10,420 +186	+2%	+$6.29K	0.17%	107
2014 Q4	$329K	Sell	10,234 -1,521	-13%	-$44K	0.17%	109
2014 Q3	$330K	Buy	11,755 +700	+6%	+$21.3K	0.18%	105
2014 Q2	$334K	Buy	11,055 +144	+1%	+$3.98K	0.17%	105
2014 Q1	$302K	Buy	10,911 +1,997	+22%	+$52.3K	0.18%	97
2013 Q4	$228K	Buy	8,914 +165	+2%	+$5.08K	0.15%	102
2013 Q3	$261K	Sell	8,749 -480	-5%	-$13.3K	0.19%	85
2013 Q2	$265K	Buy	+9,229	New	+$254K	0.19%	85

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Gilman Hill Asset Management's BRLI Position: Q3 2015 in Review

Gilman Hill Asset Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 11,605 shares — an estimated $479K sold.

Gilman Hill Asset Management first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $479K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Gilman Hill Asset Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Gilman Hill Asset Management sold 11,605 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $479K.
Gilman Hill Asset Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Gilman Hill Asset Management's BIO-REFERENCE LABS INC-NEW- position peaked at $479K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Gilman Hill Asset Management's 13F filing for Q3 2015, filed 22 Oct 2015.